These guys have better brand recognition and revenue vs expenses. Also they have one brand for 5 countries with only 1 language if I remember serves me. Anyways time will tell whether rerating comes.
ACW This biotech stock raised $11M in a risk-off environment. Its Alzheimer's drug could change the game
History-making uranium sample grades and an imminent drill run. Infini Resources is poised to transform in 2025